BLACK WEEKSBočice −15% · kompleti −10% · ostalo −5%s kodomBesplatna dostava u Njemačkoj od 200 €

Ova je stranica automatski prevedena i može sadržavati pogreške. Jeste li izvorni govornik? Rado ćemo primiti vaše povratne informacije i ispravke.Pošaljite povratne informacije

The Peptide Desk The Peptide Desk
Retatrutide, fotografija proizvoda

7 laboratorijskih izvješća

PDF
99%
Čistoća
Testirano
Retatrutide 10mg
Laboratorij
Analiza Białek
Datum
November 2026
Rezultat
99% purity (10.37 mg measured)
Endotoksini
5.54 EU/vial
Br. narudžbe
Lozinka

Neovisno testirano, može se provjeriti lozinkom izravno u laboratoriju.

GLP-1

Retatrutide

GLP-1

Narudžba

Jedinična cijena - Besplatna dostava u Njemačkoj iznad 200 € tijekom akcije Black Weeks
  • DHL s praćenjem
  • Diskretno pakiranje

4.6 od 5 na Trustpilotu73 recenzija

Traženo i kao: Retatrutid · Reta · LY3437943

Na prvi pogled

Retatrutide u brojkama

Ključni podaci iz našeg leksikona. Povucite točku po krivulji i pogledajte koliko, prema izračunu, ostaje nakon jedne doze.

Cijeli članak u leksikonu

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~6 days

Half-life ~6 days
After 12 days: 25 %
Day 650 %Day 7, next dose45 %Day 1225 %Day 1812.5 %Day 303.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

~6days

Class
Triple agonistGLP-1 / GIP / glucagon
Frequency
Once weeklysubcutaneous
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 60 mg11 sizes in the shop

Znanje

Sve o Retatrutide

Detaljne informacije uskoro.

Dobro je imati

Što vam uz to treba

Bakteriostatska voda automatski se dodaje u košaricu. Štrcaljke i maramice jednim klikom.

Inzulinske štrcaljke

10 kom. · 5.50 €

Alkoholne maramice

50 kom. · 10 €

Koliko vode?

Jedinice na štrcaljki za veličinu vaše bočice.

Otvori kalkulator →

FAQ

Česta pitanja

Izvori za svaki odgovor: članak u leksikonu

Imate još pitanja?

Pišite nam, naš tim će vam pomoći.

Is Retatrutide approved?

No, as of 25 October 2026 there is no approval. Retatrutide is in phase 3: 14 phase 3 trials are listed on ClinicalTrials.gov, five of them completed. The first phase 3 results were published in 2026.

How does Retatrutide differ from Tirzepatide and Semaglutide?

The number of receptors. Semaglutide acts only on the GLP-1 receptor, Tirzepatide on GLP-1 and GIP. Retatrutide also targets the glucagon receptor. In animal models this added higher energy expenditure. A head-to-head trial against Tirzepatide is still running (TRIUMPH-5).

What did the phase 3 trials show?

In TRIUMPH-1 (obesity without diabetes) weight fell by 25.0 percent on average after 80 weeks at the highest study dose, by 3.9 percent on placebo. In TRIUMPH-2 (with type 2 diabetes) it was 18.8 versus 5.1 percent. In TRANSCEND-T2D-1 long-term blood sugar (HbA1c) fell by up to 1.94 percentage points in 40 weeks.

What happens to liver fat?

In a substudy with fatty liver (MASLD) liver fat fell by about 81 to 82 percent after 24 weeks in the two higher levels. 86 percent reached normal liver fat below 5 percent at the highest level. A large phase 3 trial on liver disease runs until 2030.

Which side effects were seen?

Most often gastrointestinal effects such as nausea and diarrhoea, depending on the dose. In TRIUMPH-2 abnormal skin sensations (dysaesthesia) and low blood pressure occurred more often than on placebo. In the phase 2 trial heart rate rose in a dose-dependent way, most around week 24.

Which trials are still running?

Nine phase 3 trials are not finished yet. The largest: TRIUMPH-OUTCOMES on heart and kidney events with about 10,000 participants (planned end 2029) and SYNERGY-Outcomes on fatty liver (2030). The comparison with Tirzepatide (TRIUMPH-5) is due to reach its primary endpoint in November 2026.

Usporedbe

Kako se uspoređuje

Povezano

Srodni proizvodi